• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/155 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/155

Total number of patents in this class: 383

10-year publication summary

24
27
29
19
15
28
15
18
15
3
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4793
10
The Regents of the University of California
20447
10
Duke University
3167
7
Boehringer Ingelheim International GmbH
4576
6
Amyris, Inc.
373
6
The Cooper Health System
42
6
Nerviano Medical Sciences S.r.l.
245
6
Janssen Pharmaceutica N.V.
3298
5
Abbott Laboratories
2329
5
President and Fellows of Harvard College
6065
5
Aurimmed Pharma, Inc.
7
5
CHDI Foundation, Inc.
105
5
SRI International
994
5
Tetraphase Pharmaceuticals, Inc.
52
5
VALO Health, Inc.
184
5
Centre National de La Recherche Scientifique
10830
4
The General Hospital Corporation
4805
4
Abbvie Inc.
1832
4
Arena Pharmaceuticals, Inc.
361
4
Genfit
282
4
Other owners 272